Raymond James & Associates’s Vitamin Shoppe Inc. VSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-21,077
Closed -$425K 3475
2017
Q1
$425K Buy
21,077
+1,759
+9% +$37.5K ﹤0.01% 2485
2016
Q4
$459K Sell
19,318
-459
-2% -$11.8K ﹤0.01% 2389
2016
Q3
$531K Buy
19,777
+3,108
+19% +$88.3K ﹤0.01% 2245
2016
Q2
$510K Buy
16,669
+1,254
+8% +$37.1K ﹤0.01% 2094
2016
Q1
$477K Buy
15,415
+322
+2% +$9.68K ﹤0.01% 2067
2015
Q4
$494K Buy
15,093
+1,441
+11% +$45.7K ﹤0.01% 1991
2015
Q3
$446K Sell
13,652
-18,458
-57% -$658K ﹤0.01% 1977
2015
Q2
$1.2M Buy
32,110
+4,201
+15% +$168K ﹤0.01% 1630
2015
Q1
$1.15M Sell
27,909
-10,360
-27% -$438K 0.01% 1579
2014
Q4
$1.86M Buy
+38,269
New +$1.76M 0.01% 1202

Other funds holding VSI

Raymond James & Associates's VSI Position: Q2 2017 in Review

Raymond James & Associates sold out of Vitamin Shoppe Inc. (VSI) in Q2 2017, closing a stake of 21,077 shares — an estimated $425K sold.

Raymond James & Associates first reported a position in VSI in Q4 2014 and held it in 10 quarters. The position peaked at $1.86M in Q4 2014. 135 funds tracked by Wall St. Rank hold VSI as of Q2 2017.

  • Raymond James & Associates reported no remaining Vitamin Shoppe Inc. position as of Q2 2017 after selling out during the quarter.
  • Raymond James & Associates sold 21,077 Vitamin Shoppe Inc. shares in Q2 2017, an estimated $425K.
  • Raymond James & Associates first reported a position in Vitamin Shoppe Inc. in Q4 2014 and held it in 10 quarters.
  • Raymond James & Associates's Vitamin Shoppe Inc. position peaked at $1.86M in Q4 2014.
  • 135 funds tracked by Wall St. Rank held Vitamin Shoppe Inc. as of Q2 2017.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.